Journey Medical Corp News and Activities

Journey Medical Corp is owned by Fortress Biotech.

Fortress Biotech is a company listed under the stock ticker FBIO (US).

Fortress Biotech has 4 subsidiaries including Avenue Therapeutics, Checkpoint Therapeutics and Journey Medical Corp.

They are in:

• Biotechnology80%
• Pharmaceuticals20%

View the org chart displaying its 12 main executives

Most searched biographies at Journey Medical Corp

• Claude Maraoui, Director, President and Chief Executive Officer
• Justin Smith, Director
• Michael Pearce, Director

Popular executive movements at Fortress Biotech

• George Avgerinos, Senior Vice President, Biologics Operations, has left the company  (posted on November 28 2025).

Create your alert
to follow the executive moves at Journey Medical Corp.

Fortress Biotech has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Journey Medical Corp

• Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
• Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
• Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
• Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
• Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™
• Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
• Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
• Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
• Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
• Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
• View more press releases Close

Social media about Journey Medical Corp

• Journey Medical Corp on Wikipedia, Google News & Yahoo Finance
• Journey Medical Corp on LinkedIn, X (Twitter) & YouTube